Phreesia Partners with CONVINCE USA on Vaccine Hesitancy Initiative
March 09 2021 - 8:46AM
Business Wire
More than 300,000 Survey Responses Collected to
Date Provide Insights on Hesitancy Rates and Barriers to Access
Among Essential Workers, Older Adults
Phreesia, the nation’s leading patient intake platform, is
pleased to announce it has partnered with the CONVINCE USA
initiative at the CUNY Graduate School of Public Health &
Health Policy (CUNY SPH) to create a patient survey and data-driven
education tool to better understand and address patients’ COVID-19
vaccine hesitancy. To date, more than 300,000 survey responses have
been collected across Phreesia’s nationwide network, providing
valuable insights that can enable targeted interventions to engage
and inform more hesitant groups and shed light on the relationship
between access and hesitancy.
For example, while 78% of respondents 65 and older reported that
they were likely to get the vaccine, less than half of essential
workers said they were likely to be vaccinated, according to
initial survey data. Additionally, a significant number of
respondents who expressed hesitancy were more likely to get the
vaccine if it were recommended by their doctor or nurse.
The COVID-19 vaccine hesitancy survey has been implemented by
leading health systems and federally qualified health centers,
including Ascension, a faith-based national health system that
serves 19 states, and HealthLinc, an FQHC with clinics across
Northern Indiana.
CONVINCE USA is part of a global partnership with the Vaccine
Confidence Project of the London School of Hygiene & Tropical
Medicine and Wilton Park. CONVINCE USA has received funds from CDC
Foundation and The Commonwealth Fund to study trust and other
factors that influence people’s willingness to accept new COVID-19
vaccines, and to promote inclusive public dialogue to reduce
vaccine hesitancy.
“We’re excited to have the opportunity to collaborate with
Phreesia on an initiative that will help healthcare organizations
listen and respond to people’s questions about the COVID-19
vaccines at an unprecedented scale,” says Scott Ratzan MD,
Distinguished Lecturer at CUNY SPH and Executive Director of
CONVINCE USA. “Trust is critical to a long-term sustainable model
of vaccination, and we are pleased to lend our academic and
consulting expertise to help deliver evidence-based insights to
Phreesia’s clients that will foster that community trust.”
The survey asks patients a series of questions during intake to
assess their level and source of hesitancy, as well as to determine
whether they are part of a group prioritized to receive the
vaccine, such as those older than 65 and essential workers.
Patients are also asked about challenges they face in accessing the
vaccine. They then may be prompted to sign up for a waitlist or
schedule an appointment to get the vaccine.
The survey also equips providers with patient responses so that
they can address hesitancy in real time during the patient visit
and understand hesitancy and barriers to access at a community
level. Data from the survey tool—along with best practices from the
field—will be used to develop tailored education that will be
delivered to patients based on their specific vaccine concerns.
The hesitancy survey is one component of Phreesia’s Vaccine
Management Solution, an end-to-end set of tools that enables
providers to communicate with patients, manage vaccine waitlists,
automate patient intake for vaccine visits and maximize uptake by
delivering personalized messaging based on the vaccine hesitancy
survey results.
“While we are supporting the rapid digital enablement of
vaccination sites across the country, we are simultaneously focused
on hesitancy—especially increasing access and uptake in communities
hardest hit by the virus,” said Hilary Hatch, PhD, Phreesia’s VP of
Clinical Engagement. “The data we collect—guided by the deep
subject matter expertise of CONVINCE USA—gives providers and
policymakers actionable insights to address hesitancy and access on
the patient, community and national level.”
The survey asks patients their top reasons for getting a
COVID-19 vaccine, as well as their top concerns. Available answers
for patient concerns include vaccine safety, how quickly the
COVID-19 vaccines were developed, and general mistrust of vaccines
and the healthcare system—an issue in communities of color that
have been affected most by the pandemic. The survey is adaptive and
updated based on best practices and knowledge from the field.
“Data-driven solutions will be key as we work to resolve the
issue of vaccine hesitancy,” said Joseph Cacchione, MD, Executive
Vice President of Clinical & Network Services for Ascension,
which launched its hesitancy survey in mid-January. “With the
information collected by Phreesia, we’re better positioned to meet
people where they are and deliver educational content on their own
mobile devices, rather than wait for them to come to us.”
About Phreesia
Phreesia gives healthcare organizations a suite of robust
applications to manage the patient intake process. Our innovative
SaaS platform engages patients in their healthcare and provides a
safe, convenient experience, while enabling our clients to enhance
clinical care and drive efficiency.
About CUNY SPH
The CUNY Graduate School of Public Health and Health Policy
(CUNY SPH) is committed to teaching, research, and service that
creates a healthier New York City and helps promote equitable,
efficient, and evidence-based solutions to pressing health problems
facing cities around the world. Located in Harlem, CUNY SPH is the
top-ranked public school of public health in New York City, New
York State, and the tristate region.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210309005711/en/
Annie Harris aharris@phreesia.com 929-526-2611
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Jul 2023 to Jul 2024